SEYMOUR TAMARA A 4
4 · Kintara Therapeutics, Inc. · Filed Jul 5, 2022
Insider Transaction Report
Form 4
SEYMOUR TAMARA A
Director
Transactions
- Award
Options (Right to Buy)
2022-07-01+100,000→ 100,000 totalExercise: $0.26Exp: 2032-07-01→ Common Stock (100,000 underlying)
Footnotes (1)
- [F1]The option award was made to reporting person pursuant to the 2017 Omnibus Equity Incentive Plan, as amended. Subject to continued service, the options vest in 12 equal monthly installments commencing on August 1, 2022.